MTA1-TJP1 interaction and its involvement in non-small cell lung cancer metastasis

Area of Science:

• Oncology
• Molecular Biology
• Cell Biology

Background:

• Distant metastasis is a primary cause of mortality in non-small cell lung cancer (NSCLC).
• The precise role of metastasis-associated protein 1 (MTA1) in NSCLC progression remains incompletely understood.
• MTA1 is frequently overexpressed in NSCLC tissues, correlating with advanced tumor stages.

Purpose of the Study:

• To elucidate the mechanism by which MTA1 influences invasion and metastasis in NSCLC.
• To identify key interacting proteins involved in MTA1-mediated cellular changes.
• To evaluate the therapeutic potential of targeting the MTA1 pathway in NSCLC.

Main Methods:

• Bioinformatic analysis and previous experimental data.
• CRISPR/Cas9 gene editing to knockout MTA1 in H1299 cells.
• Lentivirus-mediated stable overexpression of MTA1 in A549 cells.
• In vivo lung metastasis model in nude mice.
• Immunoprecipitation and mass spectrometry to identify MTA1 interacting proteins.
• Western blotting to assess protein expression levels.
• Rescue assays to validate functional interactions.

Main Results:

• MTA1 knockout inhibited H1299 cell migration and invasion while enhancing adhesion.
• MTA1 overexpression had opposite effects on A549 cell migration, invasion, and adhesion.
• In vivo studies confirmed MTA1 promotes lung metastasis.
• Tight junction protein 1 (TJP1) was identified as an MTA1 interacting protein.
• MTA1 suppressed TJP1 expression, leading to weakened cell-cell tight junctions.
• TJP1 partially rescued MTA1-induced alterations in cell adhesion, migration, and invasion.

Conclusions:

• MTA1 promotes NSCLC invasion and metastasis by downregulating TJP1 expression.
• This interaction weakens intercellular tight junctions, altering cell adhesion and motility.
• The MTA1-TJP1 axis represents a potential therapeutic target for mitigating NSCLC metastasis.